Belgium · 
What does V-Bio Ventures invest in?
V-Bio Ventures invests most often at Series A and Series B (100% of the rounds on record), in sectors such as Therapeutics, Drug Discovery and Drug Development.
V-Bio Ventures highlights
- 01
6 rounds on record
- 02
Mostly Series A and Series B: 100% of its rounds
- 03
Led 3 rounds
What they do
We are a life science Venture Capital fund that co-creates startups and invests in early- to mid-stage companies with high growth potential.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries B
- Sectors
- TherapeuticsDrug DiscoveryDrug Development
- Based in
- Ghent, Belgium
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first6 appearances
- 2024
1 round
- Jul
- 2023
1 round
- Jan
- 2019
2 rounds
- May
- Apr
- 2018
2 rounds
- Nov
- Feb
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
11 of 16 we have independently watched raise
AgomabAnimabApheaAtbtherapeuticsAvidicureConfotherapeuticsMunatherapeuticsProtealisRootwaveSibyllabiotechStep-phArctherapeuticsBiodolCorteriapharmaExevirOrionisbio
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.